• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳酸脱氢酶 5 在头颈部鳞状细胞癌中的表达与根治性或术后放疗后的预后相关。

Lactate dehydrogenase 5 expression in squamous cell head and neck cancer relates to prognosis following radical or postoperative radiotherapy.

机构信息

Department of Radiotherapy, Democritus University of Thrace, Alexandroupolis, Greece.

出版信息

Oncology. 2009;77(5):285-92. doi: 10.1159/000259260. Epub 2009 Nov 16.

DOI:10.1159/000259260
PMID:19923867
Abstract

OBJECTIVES

We assessed the expression and the prognostic role of lactate dehydrogenase 5 (LDH5, the major LDH isoenzyme involved in anaerobic glycolysis) in patients with squamous cell head and neck cancer (SCHNC).

METHODS

LDH5 was assessed immunohistochemically in whole tissue sections from 141 patients with SCHNC. Of these, 102 were subjected to surgery with (90 patients) or without (12 patients) postoperative radiotherapy (group A), while 39 patients were treated with radical radiotherapy (group B).

RESULTS

Mixed nuclear/cytoplasmic LDH5 expression was detected in 72.5% of group A and 61.5% of group B patients. This was significantly related to T4-stage (p = 0.04) and hypoxia-inducible factor-1alpha (HIF-1alpha) expression (p = 0.002). In group A, high LDH5 was linked with poorer distant metastasis-free survival (p = 0.01) and disease-specific overall survival (OS; p = 0.009). In multivariate analysis, LDH5 (p = 0.002) and HIF-1alpha (p = 0.01) were independently linked with distant metastasis. LDH5 was also linked with death events (p = 0.005). In group B, high LDH5 expression was significantly associated with poorer local relapse-free survival (p = 0.009) and OS (p = 0.01). In multivariate analysis, only T stage was a significant predictor of death events (p = 0.04).

CONCLUSIONS

LDH5 is highly expressed in SCHNC and is linked with local relapse, survival and distant metastasis, suggesting that LDH5 is a marker of radioresistance and a target for therapeutic interventions.

摘要

目的

我们评估了乳酸脱氢酶 5(LDH5,主要的与无氧糖酵解有关的同工酶)在头颈部鳞状细胞癌(SCHNC)患者中的表达及其预后作用。

方法

采用免疫组织化学方法检测 141 例 SCHNC 患者的整块组织切片中的 LDH5。其中,90 例接受了手术治疗,其中 90 例接受了术后放疗(A 组),12 例未接受术后放疗(A 组),39 例接受了根治性放疗(B 组)。

结果

A 组和 B 组患者中分别有 72.5%和 61.5%的患者检测到混合核/浆 LDH5 表达。这与 T4 期(p=0.04)和缺氧诱导因子-1α(HIF-1α)表达(p=0.002)显著相关。在 A 组中,高 LDH5 与远处无转移生存(p=0.01)和疾病特异性总生存(OS;p=0.009)较差相关。多变量分析显示,LDH5(p=0.002)和 HIF-1α(p=0.01)与远处转移独立相关。LDH5 也与死亡事件相关(p=0.005)。在 B 组中,高 LDH5 表达与局部无复发生存(p=0.009)和 OS(p=0.01)较差显著相关。多变量分析显示,只有 T 分期是死亡事件的显著预测因素(p=0.04)。

结论

LDH5 在 SCHNC 中高度表达,与局部复发、生存和远处转移相关,提示 LDH5 是放射抵抗的标志物,也是治疗干预的靶点。

相似文献

1
Lactate dehydrogenase 5 expression in squamous cell head and neck cancer relates to prognosis following radical or postoperative radiotherapy.乳酸脱氢酶 5 在头颈部鳞状细胞癌中的表达与根治性或术后放疗后的预后相关。
Oncology. 2009;77(5):285-92. doi: 10.1159/000259260. Epub 2009 Nov 16.
2
Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients.头颈部癌中的缺氧诱导因子HIF-1α和HIF-2α:与手术切除患者肿瘤生物学及治疗结果的关系
Cancer Res. 2002 May 1;62(9):2493-7.
3
Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis.乳酸脱氢酶-5(LDH-5)在人胃癌中的表达:与缺氧诱导因子(HIF-1α)途径、血管生成因子产生及预后不良的关系
Ann Surg Oncol. 2008 Aug;15(8):2336-44. doi: 10.1245/s10434-008-9955-5. Epub 2008 Jun 3.
4
Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.可手术切除的结直肠癌中乳酸脱氢酶5的表达:与生存率及血管内皮生长因子途径激活密切相关——肿瘤血管生成研究组报告
J Clin Oncol. 2006 Sep 10;24(26):4301-8. doi: 10.1200/JCO.2006.05.9501. Epub 2006 Aug 8.
5
Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.头颈部鳞状细胞癌中拓扑异构酶IIα的表达
Anticancer Res. 2000 Jan-Feb;20(1A):177-82.
6
Treatment results on advanced neck metastasis (N3) from head and neck squamous carcinoma.头颈部鳞状细胞癌晚期颈部转移(N3)的治疗结果。
Otolaryngol Head Neck Surg. 2005 Jun;132(6):862-8. doi: 10.1016/j.otohns.2005.01.034.
7
Serum and tissue LDH levels in patients with breast/gynaecological cancer and benign diseases.乳腺癌/妇科癌症患者及良性疾病患者的血清和组织乳酸脱氢酶水平
Gynecol Obstet Invest. 2009;67(3):162-8. doi: 10.1159/000183250. Epub 2008 Dec 16.
8
Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.头颈部鳞状细胞癌细胞系中缺氧诱导因子-1α的失调与侵袭潜能相关。
Laryngoscope. 2004 Mar;114(3):418-23. doi: 10.1097/00005537-200403000-00006.
9
Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.缺氧诱导因子-1α水平可独立预测淋巴结阴性乳腺癌患者的预后。
Cancer. 2003 Mar 15;97(6):1573-81. doi: 10.1002/cncr.11246.
10
Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma.缺氧诱导因子1α的表达可预测IIIB期宫颈鳞状细胞癌单纯放疗后的无转移生存期。
Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):513-21. doi: 10.1016/j.ijrobp.2004.03.025.

引用本文的文献

1
Lactylation in Tumor Immune Escape and Immunotherapy: Multifaceted Functions and Therapeutic Strategies.肿瘤免疫逃逸与免疫治疗中的乳酸化修饰:多方面功能与治疗策略
Research (Wash D C). 2025 Sep 11;8:0793. doi: 10.34133/research.0793. eCollection 2025.
2
Lactate Is a Major Promotor of Breast Cancer Cell Aggressiveness.乳酸是乳腺癌细胞侵袭性的主要促进因子。
Cancers (Basel). 2025 May 27;17(11):1793. doi: 10.3390/cancers17111793.
3
The role and mechanism of aerobic glycolysis in nasopharyngeal carcinoma.有氧糖酵解在鼻咽癌中的作用及机制
PeerJ. 2025 Apr 2;13:e19213. doi: 10.7717/peerj.19213. eCollection 2025.
4
Lactate in skin homeostasis: metabolism, skin barrier, and immunomodulation.皮肤稳态中的乳酸:代谢、皮肤屏障与免疫调节
Front Immunol. 2025 Feb 19;16:1510559. doi: 10.3389/fimmu.2025.1510559. eCollection 2025.
5
Development of a novel lactate dehydrogenase A inhibitor with potent antitumor activity and immune activation.开发一种新型乳酸脱氢酶 A 抑制剂,具有强大的抗肿瘤活性和免疫激活作用。
Cancer Sci. 2022 Sep;113(9):2974-2985. doi: 10.1111/cas.15468. Epub 2022 Jul 11.
6
Metabolic response to radiation therapy in cancer.癌症放射治疗的代谢反应。
Mol Carcinog. 2022 Feb;61(2):200-224. doi: 10.1002/mc.23379. Epub 2021 Dec 27.
7
Lactate Dehydrogenase A or B Knockdown Reduces Lactate Production and Inhibits Breast Cancer Cell Motility .乳酸脱氢酶A或B基因敲低可减少乳酸生成并抑制乳腺癌细胞迁移。
Front Pharmacol. 2021 Oct 20;12:747001. doi: 10.3389/fphar.2021.747001. eCollection 2021.
8
Application of the ESMACS Binding Free Energy Protocol to a Multi-Binding Site Lactate Dehydogenase A Ligand Dataset.ESMACS结合自由能协议在多结合位点乳酸脱氢酶A配体数据集上的应用。
Adv Theory Simul. 2020 Jan;3(1):1900194. doi: 10.1002/adts.201900194. Epub 2019 Nov 18.
9
Monitoring Early Glycolytic Flux Alterations Following Radiotherapy in Cancer and Immune Cells: Hyperpolarized Carbon-13 Magnetic Resonance Imaging Study.癌症与免疫细胞放疗后早期糖酵解通量变化的监测:超极化碳-13磁共振成像研究
Metabolites. 2021 Aug 6;11(8):518. doi: 10.3390/metabo11080518.
10
Hypoxia‑induced lactate dehydrogenase A protects cells from apoptosis in endometriosis.缺氧诱导的乳酸脱氢酶 A 可保护子宫内膜异位症中的细胞免于凋亡。
Mol Med Rep. 2021 Sep;24(3). doi: 10.3892/mmr.2021.12276. Epub 2021 Jul 19.